TXG – 10x genomics, inc. (US:NASDAQ)
Stock Stats
News
10x Genomics (TXG) was upgraded by Zacks Research from "hold" to "strong-buy".
10x Genomics (TXG) had its price target raised by Canaccord Genuity Group Inc. from $22.00 to $32.00. They now have a "buy" rating on the stock.
10x Genomics (TXG) had its price target raised by Bank of America Corporation from $21.00 to $30.00. They now have a "neutral" rating on the stock.
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood [Yahoo! Finance]
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood [TheStreet.com]
Form 4 10x Genomics, Inc. For: Apr 14 Filed by: Saxonov Serge
Form 4 10x Genomics, Inc. For: Mar 23 Filed by: Saxonov Serge
Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: VANGUARD GROUP INC
Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: VANGUARD GROUP INC
Form SCHEDULE 13G/A 10x Genomics, Inc. Filed by: FMR LLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.